A Quote by David Mixner

Pharmaceutical companies have invested hundreds of millions of dollars in new HIV/AIDS treatments not out of altruism but because they can make up those research costs in sales.
New York City must divest the hundreds of millions of dollars we have invested in Walmart for far too long, dollars that are only fueling violence and undermining the greater public interest. Once our nation's largest city does so, I know other states and municipalities will follow suit.
I'm part of a team that raises millions of dollars and raises awareness of HIV and AIDS all over the world.
HIV/AIDS is the greatest danger we have faced for many, many centuries. HIV/AIDS is worse than a war. It is like a world war. Millions of people are dying from it.
HIV/AIDS from converted from a lethal disease into a chronic disease because basic scientists' fundamental research was done that illuminated aspects of that virus and allowed the generation of therapies like antiretroviral therapies. And so now HIV/AIDS is not a lethal disease, it is a chronic disease.
You can think of the Health Impact Fund as a mechanism that would keep the benefits and burdens of pharmaceutical innovation for the affluent roughly as they are while massively reducing the burdens presently imposed upon the poor. This sounds like magic. But it really works because the current system is not Pareto efficient. It's a system that generates hundreds of billions of dollars in litigation costs and deadweight losses that HIF-registered medicines would sidestep. By avoiding these losses, the HIF reform can bring improvements all around - including for pharmaceutical innovators.
If people are encouraged to come out and say they're HIV-positive and they're given their treatments, then obviously, the people who are marginalized - like intravenous drug users, prisoners, people are made to feel less-than - if they're given the support of the government, and they're given the funding, then it's going to help solve the spread of AIDS and HIV in America.
It's easy to complain that pharmaceutical companies place profits over people and apparently care more about hair loss than TB. However, many in the pharmaceutical industry would be glad for the opportunity to reorient their research toward medicines that are truly needed, provided only that such research is financially sustainable.
As a new mother, I want to give my children the best start in life but millions of children affected with AIDS don't live with such certainty. We can all do something to give them a future worth living for. We can make a difference in a child's life by joining with UNICEF to ensure that mothers and children are given the treatment that they deserve, in order to live a life free from HIV and AIDS.
One dirty tactic big pharmaceutical companies use is keeping drug prices artificially high through anti-competitive conduct, such as paying competitors millions of dollars to stop them from creating generic drugs.
In a large pharmaceutical company, where it's a big bet, you're going to need finance people to be involved in the decision-making because the investment can run into the hundreds of millions of dollars. You're going to have to run scenarios. You might even need agreement from the C.E.O. to make that type of decision. If it's an incremental, low-cost decision in a marketing-oriented company, it may be a very different set of stakeholders a lot further down in the organization.
Just to be clear, if, like Pat Robertson, you somehow missed all the evidence, all the research, the depth and breadth of all the knowledge garnered about HIV and AIDS over the past three decades, you cannot get HIV if you share towels.
Pharmaceutical companies are very annoyed with niacin because their products have to compete with it. Some of their cholesterol-lowering drugs cost up to $150 a month while niacin costs about $10.
90 percent of the cost of malaria drugs has come down because of the work of the Clinton Foundation. There are over 10 million people around the globe today receiving life-saving HIV and AIDS drug treatments because of the Clinton Foundation.
HIV AIDS is a disease with stigma. And we have learned with experience, not just with HIV AIDS but with other diseases, countries for many reasons are sometimes hesitant to admit they have a problem.
The boom was healthy too, even with its excesses. Because what this incredible valuation craze did was draw untold sums of billions of dollars into building the Internet infrastructure. The hundreds of billions of dollars that got invested in telecommunications, for example.
To tell you the truth, I'm shocked, as I travel across this country, at how little people know or don't want to know about HIV/AIDS. There are a lot of people who don't know that HIV is one thing and AIDS is another. Those people just think it's one big old alphabet of a disease.
This site uses cookies to ensure you get the best experience. More info...
Got it!